Basic and clinical aspects of bradykinin receptor antagonists

Progress in Drug Research

Volumn 69, Issue , 2014, Pages 1-14

  Sharma, Jagdish N ^a  

^a KUWAIT UNIVERSITY   (Kuwait)

Author keywords

[No Author keywords available]

Indexed keywords

BRADYKININ ANTAGONIST; BRADYKININ B1 RECEPTOR; BRADYKININ B1 RECEPTOR ANTAGONIST; BRADYKININ B2 RECEPTOR; BRADYKININ B2 RECEPTOR ANTAGONIST; BRADYKININ B3 RECEPTOR; BRADYKININ B3 RECEPTOR ANTAGONIST; ICATIBANT; KALLIDIN; UNCLASSIFIED DRUG;

ACUTE HEART INFARCTION; ALLERGIC RHINITIS; ANALGESIC ACTIVITY; ANGIONEUROTIC EDEMA; ANTIINFLAMMATORY ACTIVITY; ANTINEOPLASTIC ACTIVITY; ARTICLE; ASTHMA; BLOOD VESSEL PERMEABILITY; BRONCHOCONSTRICTION; DRUG CONTRAINDICATION; DRUG MECHANISM; DRUG STRUCTURE; HUMAN; HYPERTENSIVE CRISIS; NONHUMAN; OSTEOLYSIS; OSTEOMYELITIS; PAIN; PATHOGENESIS; PATHOPHYSIOLOGY; PAW EDEMA; PERIODONTITIS; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; RHEUMATOID ARTHRITIS; SECOND MESSENGER; SORE THROAT; STRUCTURE ACTIVITY RELATION;

ANIMALS; ANTI-INFLAMMATORY AGENTS; BRADYKININ; CARDIOVASCULAR AGENTS; HUMANS; LIGANDS; RECEPTORS, BRADYKININ; SIGNAL TRANSDUCTION;

EID: 84904406807     PISSN: 0071786X     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-3-319-06683-7_1     Document Type: Article

References (71)

1. Abe K, Watanabe N, Kumagai N et al (1967) Circulating plasma kinin in patients with bronchial asthma. Experientia 23:626-627
2. Armstrong D, Dry RML, Keele CA et al (1951) Method for studying chemical excitants of cutaneous pain in man. J Physiol 120:326-351
3. Barabe J, Droulin JN, Regoli D et al (1977) Receptors for bradykinin in intestine and uterine smooth muscle. Can J Physiol Pharmacol 96:920-926
4. Benton HP, Jackson TR, Hanley MR (1989) Identification of a novel inflammatory stimulant of chondrocytes. Biochem J 269:861-867
5. Berg T, Schlichting E, Ishida H et al (1989) Kinin antagonist does not protect against the hypotensive response to endotoxin, anaphylaxis or acute pancreatitis. J Pharmacol Exp Ther 251:731-734
6. Bishop JM, Harris P, Segel N (1965) The circulatory effects of bradykinin in normal subjects and patients with chronic bronchitis. Br J Pharmacol Chemother. 25:456-460
7. Bouthiller J, Deblois D, Marceau F (1987) Studies on the induction of pharmacological responses to des-Arg9-bradykinin in vitro and vivo. Br J Pharmacol 92:257-264
8. Burch RM (1989) Diacylglycerol in the synergy of bradykinin and thrombin stimulation of prostaglandin synthesis. Eur J Pharmac. 168:39-42
9. Burch RM (1990) Kinin signal transduction: role of phosphoinositides and eicosanoids. J Cardiovasc Pharmacol 15(Suppl. 6):S44-S45
10. Burch RM, Axelrod J (1987) Dissociation of bradykinin-stimulated arachidonic acid release from inositol phosphate formation in Swiss 3T3 fibroblasts. Evidence for a G protein-coupled phospholipase A2. Proc Natn Acad Sci 84:6374-6378
11. Burch RM, DeHaas C (1990) A bradykinin antagonist inhibits carrageenan edema in rats. Naunyn-Sehmiedeberg's Arch Pharmac 342:189-193
12. Burch RM, Farmer SS, Steranka LR (1990) Bradykinin receptor antagonists. Med Res Rev 10:237-269
13. Carr J, Wilhelm DL (1964) The evaluation of increased vascular permeability in the skin of guinea-pig. Aust J Exp Biol Med Sci 42:511-517
14. Cicardi M, Banerji A, Bracho F (2010) Icatibant, a new bradykinin-receptor antagonist, in hereditary angioedema. N Engl J Med 363:532-541
15. Christiansen SC, Proud D, Cochrane CG (1987) Detection of tissue kallikrein in the bronchoalveolar lavage fluid of asthmatic subjects. J clin Invest 79:188-197
16. Couture R, Mizrahi J, Regoli R et al (1982) Peptides and the human colon: an in vitro pharmacological study. Can J Physiol Pharmac 59:957-970
17. D'Orleans-Juste P, de Nucci G, Vane JR (1989) Kinins act on Bt or B2 receptors to release conjointly endothelium-derived relaxing factor and prostacyclin from bovine aortic endothelial cells. Br J Pharmacol 96:920-926
18. Erdos EG (1990) Some old and some new ideas on kinin metabolism. J Cardiovasc Pharmacol 15(Suppl. 6):S20-S24
19. Erdos EG, Wohler IM, Levine MI et al (1965) Carboxy-peptidase in blood and other fluids. Values in human blood in normal and pathological conditions. Clin Chim Acta 11:39-43
20. Farmer SG, Burch RM, Meeker SA et al (1989) Evidence for a pulmonary B3 bradykinin receptor. Molec Pharmacol 36:1-8
21. Field JL, Hall JM, Morton IKM (1992) Bradykinin receptors in the guinea-pig taemia caeci are similar to proposed BK3 receptors in the guinea-pig trachea, and are blocked by HOE 140. Br J Pharmacol 105:293-296
22. Figueroa CD, Ehrenfeld P, Bhoola KD (2012) Kinin receptors as target for cancer therapy. Expt Opin Ther Targets 16:299-312
23. Freay A, Johns A, Adams DJ et al (1989) Bradykinin and inositoll,4,5-triphosphate-stimulated calcium release from intracellular stores in cultured bovine endothelial cells. Pflugers Arch 414:377-384
24. Griesbacher T, Lembeck F (1987) Effect of bradykinin antagonists on bradykinin-induced plasma extravasation, venoconstriction, prostaglandin E2 release, nociceptor stimulation and contraction of the iris sphincter muscle in the rabbit. Br J Pharmacol 92:333-340
25. Griesbacher T, Lembeck F, Saria A (1989) Effect of bradykinin antagonist B4310 on smooth muscles and blood pressure in rats, and its enzymatic degradation. Br J Pharmacol 96:531-538
26. Hashimoto K, Hamamoto H, Honda Y et al (1978) Changes in components of kinin system and hemodynamics in acute myocardial infarction. Am Heart J 95:619-626
27. Hawkinson JE, Szoke BG, Garofalo AW et al (2007) Pharmacological, pharmacokinetic, and primate analgesic efficacy profile of the novel bradykinin B1 Receptor antagonist ELN441958. J Pharmacol Exp Ther 322:619-630
28. Herxheimer A, Stresemann E (1963) Bradykinin and ethanol in bronchial asthma. Archs int Pharmacodyn Ther 144:315-321
29. Hock FJ, Wirth K, Aebus D et al (1991) Hoe 140 a new potent and long acting bradykininantagonist: in vitro studies. Br J Pharmacol 102:769-773
30. Holdstock DJ, Mathias AP, Schachter M (1957) A comparative study of kinin, kallidin and bradykinin. Br J Pharmacol Chemother 12:149-154
31. Jin LS, Seeds E, Page CP et al (1989) Inhibition of bradykinin-induced bronchoconstriction in the guinea-pig by a synthetic B2 receptor antagonist. Br J Pharmac 97:598-602
32. Juan H, Lembeck F (1974) Action of peptides and other algesic agents on paravascular pain receptors of isolated perfused rabbit ear. Naunyn Schniedeberg's Arch Pharmac 283:151-164
33. Lammek B, Wang YS, Gavras I et al (1990) A new highly potent antagonist of bradykinin. Peptides 11:1041-1043
34. Lembeck F, Griesbacher T (1990) Functional analysis of kinin antagonists. J Cardiovasc Pharmacol 15:S75-S77
35. Linz W, Scholkens A (1992) A specific B2-bradykinin receptor antagonist HOE 140 abolishes the antihypertensive effect of ramipriL. Br J Pharmacol 105:771-772
36. Liu BY, Zhang HL (2009) Bradykinin modulated ion channel in inflammatory pain. Yao Xue Xue Bao 44:1066-1071
37. Ljunggren O, Lerner DH (1990) Evidence for BKI bradykinin receptor-mediated prostaglandin formation in osteoblasts and subsequent enhancement of bone resorption. Br J Pharmac 101:382-386
38. Llona I, Vavrek R, Stewart J et al (1987) Identification of pre- and postsynaptic bradykinin receptor sites in the vas deference: evidence for structural prerequisites. J Pharmac Exp Ther 241:608-614
39. Marceau F, Barabé J, St-Pierre S et al (1980) Kinin receptors in experimental inflammation. Can J Physiol Pharmacol 58:536-542
40. Regoli D, Barabé J (1980) Pharmacology of bradykinin and related kinins. Pharmacol Rev 32:1-46
41. Regoli D, Marceau F, Lavigne J (1981) Induction of B1 receptors for kinins in the rabbit by a bacterial lipopolysaccharide. Eur J Pharmacol 71:105-115
42. Regoli D (1984) Polypeptide and antagonist. Sem Hop 60:987-1002
43. Saha JK, Sengupta JN, Goyal RK (1990) Effect of bradykinin on opossum esophageal longitudinal smooth muscle: evidence for novel bradykinin receptors. J Pharmacol Exp Ther 252:1012-1020
44. Schachter M, Uchida Y, Longridge DJ (1987) New synthetic antagonists of bradykinin. Br J Pharmacol 92:851-855
45. Schini VB, Boulanger C, Regoli D et al (1990) Bradykinin stimulates the production of cyclic GMP via activation of B2 kinin receptors in cultured porcine aortic endothelial cells. J Pharmacol Exp Ther 252:581-585
46. Sharma JN (1984) Kinin forming System in the Genesis of Hypertension. Agents Actions 14:200-205
47. Sharma JN (1988a) The Kinin System and Prostaglandins in the Intestine. Pharmacol Toxicol 63:310-316
48. Sharma JN (1988b) Interrelationship Between the Kallikrein-Kinin System and Hypertension. Gen Pharmacol 19:177-187
49. Sharma JN (1990) Does Kinin Mediate the Hypotensive Action of Angiotensin Converting Enzyme (ACE) Inhibitors? Gen Pharmacol 21:451-457
50. Sharma JN (1991a) Pro-inflammatory actions of platelet activating factor: relevant to joint inflammatory disease. Expe Pathol 43:47-50
51. Sharma JN (1991b) The role of kinin system in joint inflammatory disease. Eur J Rheumatol Inflamm 11:30-36
52. Sharma JN (1991c) The Role of Kallikrein-Kinin System in Joint Inflammatory Disease. Pharmacol Res 23:105-112
53. Sharma JN (1992) Involvement of the kinin - forming system in the physiopathology of rheumatoid inflammation. Agents Actions 38(Suppl. III):343-361
54. Sharma JN (1993) Therapeutic prospects of bradykinin receptor antagonists. Gen Pharmacol 24:267-274
55. Sharma JN, Al-Dhalmawi GS (2003) Bradykinin receptor antagonists: therapeutic implications. IDrugs 6:581-586
56. Sharma JN, Al-Sherif GJ (2006) Pharmacologic targets and prototype therapeutics in the kallikrein-kinin system: bradykinin receptor agonists or antagonists. Sci World J 6:1247-1261
57. Sharma JN, Buchanan WW (1979) Kinin system in clinical and experimental rheumatoid inflammation. Curr Med Res Opini 6:314-321
58. Sharma JN, Mohsin SSJ (1990) The role of chemical mediators in pathogenesis of inflammation with emphasis on the kinin system. Exp Pathol 38:73-96
59. Sharma JN, Stewart JM, Mohsin SSJ et al (1992) Influence of a kinin antagonist on acute hypotensive responses induced by bradykinin and captopril in spontaneously hypertensive rats. Agents Actions 38(Suppl. III): 258-269
60. Sharma JN, Wirth KJ (1996) Inhibition of rats adjuvant arthritis by a Bradykinin Antagonist Hoe 140 and its influence on kallikrein. Gen Pharmacol 27:133-136
61. Sharma JN, Zeitlin IJ (1977) Indomethacin in low concentration potentiates the action of some spasmogens on the isolated oestrous rat uterus. J Pharma Pharmacol 29:316-317
62. Shimamoto K, Ando T, Tanaka S et al (1982) An improved method for the determination of human blood kinin levels by sensitive kinin radioimmunoassay. Endocrinol Jpn 29:487-494
63. Shimamoto K, Masuda A, Ando T et al (1989) Mechanisms of suppression of renal kallikrein activity in low renin essential hypertension and renoparenchymal hypertension. Hypertension 14:375-378
64. Sleszyńska M, Kwiatkowska A, Sobolewski D et al (2009) New bradykinin B(2) receptor antagonists - influence of C-terminal segment modifications on their pharmacological properties. Acta Biochim Pol 56:641-648
65. Steranka LR, Farmer SG, Burch RM (1989) Antagonists of B2 bradykinin receptors. Faseb J 3:2019-2025
66. Steward JM (2003) Bradykinin antagonists as anticancer agents. Curr Pharma Design 9:2036-2042
67. Taylor JE, DeFeudis FV, Moreau JP (1989) Bradykinin-antagonists: Therapeutic perspectives. Drug Dev Res 16:1-11
68. Tiffany CW, Burch RM (1989) Bradykinin stimulates tumor necrosis factor and interleukin-1 release from macrophages. FEBS Lett 247:189-192
69. Torstila I (1978) The plasma kinin system in acute myocardial infarction. Acta Med Scand Suppl 620:1-62
70. Vavrek RJ, Stewart JM (1985) Competitive antagonists of bradykinin. Peptides 6:161-164
71. Whalley ET, Nwator IA, Stewart JM et al (1987) Analysis of the receptors mediating vascular actions of bradykinin. Naunyn Schmiedebergs Arch Pharmacol 336:430-433